These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19774408)

  • 1. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet's disease.
    Bilginer Y; Ayaz NA; Ozen S
    Clin Rheumatol; 2010 Feb; 29(2):209-10. PubMed ID: 19774408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
    Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
    Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
    Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
    Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
    Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
    Rheumatology (Oxford); 2020 Dec; 59(12):3892-3899. PubMed ID: 32556219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. Retrospective analysis.
    Sargin G; Kose R; Senturk T
    Sao Paulo Med J; 2019 May; 137(1):39-44. PubMed ID: 31116269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma.
    Nalcacioglu H; Ozkaya O; Genc G; Ayyildiz S; Kefeli M; Elli M; Aydin O; Ceyhan Bilgici M
    Int J Rheum Dis; 2018 Feb; 21(2):552-559. PubMed ID: 29239128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis.
    Özçakar ZB; Özdel S; Yılmaz S; Kurt-Şükür ED; Ekim M; Yalçınkaya F
    Clin Rheumatol; 2016 Feb; 35(2):441-6. PubMed ID: 25213327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.
    Sevillano ÁM; Hernandez E; Gonzalez E; Mateo I; Gutierrez E; Morales E; Praga M
    Nefrologia; 2016; 36(1):63-6. PubMed ID: 26409501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Living kidney transplantation between brothers with unrecognized renal amyloidosis as the first manifestation of familial Mediterranean fever: a case report.
    Peces R; Afonso S; Peces C; Nevado J; Selgas R
    BMC Med Genet; 2017 Aug; 18(1):97. PubMed ID: 28859624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever.
    Calligaris L; Marchetti F; Tommasini A; Ventura A
    Eur J Pediatr; 2008 Jun; 167(6):695-6. PubMed ID: 17588171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report.
    Demir F; Bahadir A; Mungan S; Çobanoğlu Ü; Kalyoncu M
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):234-237. PubMed ID: 31094904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
    Portincasa P; Scaccianoce G; Palasciano G
    Eur J Clin Invest; 2013 Dec; 43(12):1314-27. PubMed ID: 24117178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.
    Kurt T; Aydın F; Nilüfer Tekgöz P; Sezer M; Uncu N; Çelikel Acar B
    Int J Rheum Dis; 2020 Jul; 23(7):977-981. PubMed ID: 32558310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation.
    Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J
    Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever.
    Alpay N; Sumnu A; Calışkan Y; Yazıcı H; Türkmen A; Gül A
    Rheumatol Int; 2012 Oct; 32(10):3277-9. PubMed ID: 20386914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure.
    Stankovic Stojanovic K; Delmas Y; Torres PU; Peltier J; Pelle G; Jéru I; Colombat M; Grateau G
    Nephrol Dial Transplant; 2012 May; 27(5):1898-901. PubMed ID: 21931121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of nephrotic syndrome due to FMF amyloidosis with azathioprine: report of three Turkish cases.
    Sayarlioglu H; Erkoc R; Sayarlioglu M; Dogan E; Soyoral Y
    Rheumatol Int; 2006 Dec; 27(2):197-9. PubMed ID: 16944160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis.
    Tezcan ME
    Med Hypotheses; 2019 Sep; 130():109269. PubMed ID: 31383341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is colchicine therapy effective in all patients with secondary amyloidosis?
    Unverdi S; Inal S; Ceri M; Unverdi H; Batgi H; Tuna R; Ozturk MA; Guz G; Duranay M
    Ren Fail; 2013 Sep; 35(8):1071-4. PubMed ID: 23841746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Mediterranean fever in childhood: a single-center experience.
    Barut K; Sahin S; Adrovic A; Sinoplu AB; Yucel G; Pamuk G; Aydın AK; Dasdemir S; Turanlı ET; Buyru N; Kasapcopur O
    Rheumatol Int; 2018 Jan; 38(1):67-74. PubMed ID: 28828621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.